Meet MRC DTP Cohorts
Find out more about our students and their research (with some insights on studying at our institutions; MRC LID; training and placement opportunities).
| Name | Project Title | Supervisors | Primary Institution | Award | Route | |
|---|---|---|---|---|---|---|
 |
Mathew Amollo | How do childhood contexts affect violence against young people as they grow up? A quantitative, longitudinal and intersectional analysis of cohort data in Uganda | Karen Devries Daniel Carter |
LSHTM | MRC LID 2 Cohort 2 (2023-24) |
RD only (4 years FTE) |
 |
Clara Brigitta | Modelling the disorganised ecology of post-pandemic respiratory viruses | Rosalind Eggo Graham Medley |
LSHTM | MRC LID 2 Cohort 2 (2023-24) |
RD only (4 years FTE) |
 |
Pranaya Kansakar | Campylobacter pathogenesis: the Unfolded Protein Response (UPR), inflammation and human disease | Ozan Gundogdu Brendan Wren |
LSHTM | MRC LID 2 Cohort 2 (2023-24) |
RD only (4 years FTE) |
 |
Chaelin Kim | Comparing drug-resistant tuberculosis empirical treatment choices | Finn McQuaid Gwen Knight |
LSHTM | MRC LID 2 Cohort 2 (2023-24) |
RD only (4 years FTE) |
 |
Hamin Lee | Development of a transgenic mouse model for preclinical studies of therapeutic testing of mitochondrial disorders | Chris Carroll Alan Pittman |
SGUL | MRC LID 2 Cohort 2 (2023-24) |
RD only (4 years FTE) |
 |
Morgan Lemin | Data science platforms for enhanced analytics and monitoring of female genital schistosomiasis and related health impacts | Chrissy Roberts Amaya Bustinduy |
LSHTM | MRC LID 2 Cohort 2 (2023-24) |
RD only (4 years FTE) |
 |
Kathryn Mackey | Migrant health in children and young people in Europe: An analysis of Europe-wide routine datasets | Sally Hargreaves Julia Pescarini Nuria Sanchez Clemente |
SGUL | MRC LID 2 Cohort 2 (2023-24) |
RD only (4 years FTE) |
 |
David Rebellon Sanchez | Defining new asthma phenotypes using high dimensional data | Lucy Pembrey Phil Cooper Karin Van Veldhoven |
LSHTM | MRC LID 2 Cohort 2 (2023-24) |
RD only (4 years FTE) |
 |
Lucy Smith | Development, implementation and assessment of isothermal point-of-care molecular diagnostics for both Female Genital Schistosomiasis and Human Papillomavirus | Amaya Bustinduy Sanjeev Krishna Bonnie Webster |
LSHTM | MRC LID 2 Cohort 2 (2023-24) |
RD only (4 years FTE) |
 |
Gregory Barnsley | Modelling the effectiveness of antibiotic mass administration in acute humanitarian crises | Stefan Flasche Bhargavi Rao Kevin Van Zandvoort |
LSHTM | MRC LID 2 Cohort 1 (2022-23) |
RD only (4 years FTE) |
 |
Sebastian Bowyer | Developing machine learning tools to investigate evolutionary trajectories in emerging viral infectious diseases | Nick Furnham David Allen |
LSHTM | MRC LID 2 Cohort 1 (2022-23) |
RD only (4 years FTE) |
 |
Lily Hopkins | Improving the effectiveness of diabetes self-management education and behavioural support in Thailand, India, and Uganda | Sanjay Kinra Judith Leiber |
LSHTM | MRC LID 2 Cohort 1 (2022-23) |
RD only (4 years FTE) |
 |
Jamie James | An ‘unconventional’ approach to the COVID 19 pandemic: the role of γδ T cells in virus recognition | Mark Bodman-Smith Elisabetta Groppelli Javier Salguero Bodes Sally Sharpe |
SGUL | MRC LID 2 Cohort 1 (2022-23) |
RD only (4 years FTE) |
 |
Katie Latham | Viral evasion of innate immunity: have we misunderstood one of the world’s most widespread viruses? | Blair Strang Steve Goodbourn |
SGUL | MRC LID 2 Cohort 1 (2022-23) |
RD only (4 years FTE) |
 |
Karen Lau | Estimating the global burden of labour exploitation and its impact on health of migrants: Improving health outcomes and health-system responses to labour exploitation | Sally Hargreaves Megnha Ranganathan Ligia Kiss Cathy Zimmerman |
SGUL | MRC LID 2 Cohort 1 (2022-23) |
RD only (4 years FTE) |
 |
Daniel Lule | Development of novel approaches for HIV drug resistance detection using nanopore sequencing technology | Damien Tully Deogratius Ssemwanga Pontiano Kaleebu |
LSHTM | MRC LID 2 Cohort 1 (2022-23) |
RD only (4 years FTE) |
 |
Samantha Sadoo | Intrapartum-related neonatal encephalopathy in Africa: Defining burden, risk and outcomes | Cally Tann Kirsty LeDoare Eric Ohuma Hannah Blencowe |
LSHTM | MRC LID 2 Cohort 1 (2022-23) |
RD only (4 years FTE) |
 |
Maximilian Wallat | Transfer and stability of antimicrobial resistance (AMR) genes in Methicillin-Resistant Staphylococcus aureus (MRSA) | Jodi Lindsay Gwen Knight Kat Holt |
SGUL | MRC LID 2 Cohort 1 (2022-23) |
RD only (4 years FTE) |
 |
Emily Carr | The impact of Vitamin D supplementation on immune responses to respiratory pathogens in older children in Zambia with perinatally-acquired HIV-1 infection | Derek Macallan Suzanne Filteau Sarah Rowland-Jones |
SGUL | MRC LID 1 Cohort 6 (2021-22) |
RD only (3.5 years FTE) |
 |
Hannah Choi | Real-time modelling and inference of Covid-19 transmission and control | Sebastian Funk Adam Kucharski |
LSHTM | MRC LID 1 Cohort 6 (2021-22) |
RD only (3.5 years FTE) |
 |
Alastair Clements | Modelling for MRSA control: can we harness phage and antibiotics to halt resistance spread? | Gwen Knight Jodi Lindsay |
LSHTM | MRC LID 1 Cohort 6 (2021-22) |
RD only (3.5 years FTE) |
 |
Ramla Cusman | Investigating metabolic pathways that drive tissue remodelling and fibrosis in Tuberculosis | Jon Friedland Deborah Chong Rajko Reljic |
SGUL | MRC LID 1 Cohort 6 (2021-22) |
RD only (3.5 years FTE) |
 |
Sophia DonVito | High throughput approaches to strain-transcending malaria vaccine candidate selection | Rob Moon Susana Campino |
LSHTM | MRC LID 1 Cohort 6 (2021-22) |
RD only (3.5 years FTE) |
 |
Mia Harley | Understanding ethnic differences in the comparative effectiveness of antidiabetic medications using high-dimensional propensity scores in electronic health records | Christopher Rentsch Elizabeth Williamson |
LSHTM | MRC LID 1 Cohort 6 (2021-22) |
RD only (3.5 years FTE) |
 |
Emily Humphreys | Evaluating the impact of parental leave policies on women’s mental health using Quasi-Experimental Methods | Veronique Filippe Emilie Courtin Stephen O’Neill |
LSHTM | MRC LID 1 Cohort 6 (2021-22) |
RD only (3.5 years FTE) |
 |
Sarah Mulwa | Causal pathways and cost-effectiveness of DREAMS’ impact on psycho-social mediators, social norms, and adolescent health outcomes in rural and urban Kenya | Sian Floyd Isolde Birdthistle Ruth Keogh |
LSHTM | MRC LID 1 Cohort 6 (2021-22) |
RD only (3.5 years FTE) |
 |
Matthew Pryce | Double machine learning methods for estimating causal treatment effects on cancer survival outcomes in the presence of high-dimensional confounding | Ruth Keogh Karla Diaz-Ordaz |
LSHTM | MRC LID 1 Cohort 6 (2021-22) |
RD only (3.5 years FTE) iCASE |
 |
Kirsty Andresen | Matched cohort methods in the analysis of e-Health data | Krishnan Bhaskaran Elizabeth Williamson |
LSHTM | MRC LID 1 Cohort 5 (2020-21) |
RD only (3.5 years FTE) |
 |
Anna Deal | The role of migrants in outbreaks of vaccine-preventable diseases in the UK and Europe | Sally Hargreaves Sandra Mounier-Jack Jon Friedland |
SGUL | MRC LID 1 Cohort 5 (2020-21) |
RD only (3.5 years FTE) |
 |
Emilie Finch | Combining novel data streams to forecast acute febrile illness in the Dominican Republic | Adam Kucharski Rachel Lowe Sebastian Funk |
LSHTM | MRC LID 1 Cohort 5 (2020-21) |
RD only (3.5 years FTE) |
 |
Katherine Holdsworth | Use and development of statistical mediation techniques to understand the survival gap between males and females with cystic fibrosis | Ruth Keogh Stijn Vansteelandt |
LSHTM | MRC LID 1 Cohort 5 (2020-21) |
RD only (3.5 years FTE) |
 |
Hannah Johnson | Using data from EUROmediCAT to develop statistical methods to Identify medications that might harm the fetus if taken during the first trimester of pregnancy | Joan Morris Stephen Evans Iain Carey |
SGUL | MRC LID 1 Cohort 5 (2020-21) |
Masters & RD (1+3 years FTE) |
 |
Suzanne Keddie | Bayesian estimation of the aetiology of fever using big case-control data | John Bradley Ruth Keogh Oliver Baerenbold |
LSHTM | MRC LID 1 Cohort 5 (2020-21) |
RD only (3.5 years FTE) |
 |
Sophie Moss | Genomic epidemiology of Plasmodium falciparum in the context of mass drug administration for malaria control on the Bijagos Archipelago of Guinea Bissau | Anna Last Sanjeev Krishna Taane Clark |
LSHTM | MRC LID 1 Cohort 5 (2020-21) |
RD only (3.5 years FTE) |
 |
Shannan Summers | Development of molecular diagnostics for antihelmintic drug resistance monitoring in human schistosomiasis | Amaya Bustinduy Michael Miles |
LSHTM | MRC LID 1 Cohort 5 (2020-21) |
RD only (3.5 years FTE) |
 |
Ella Whittle | Utilizing whole genome sequencing to revolutionize diagnosis of neurological disorders | Chris Carroll Shamima Rahman Kate Everett |
SGUL | MRC LID 1 Cohort 5 (2020-21) |
RD only (3.5 years FTE) |
 |
Jacob Wildfire | Identification and characterisation of barriers to antimicrobial resistance gene transfer | Jodi Lindsay Gwen Knight |
SGUL | MRC LID 1 Cohort 5 (2020-21) |
RD only (3.5 years FTE) |
 |
Emma Collins | Using whole genome sequencing to characterise the genetic diversity of mosquitoes and pathogens involved in vector borne disease | Susana Campino Taane Clark |
LSHTM | MRC LID 1 Cohort 4 (2019-20) |
RD only (3.5 years FTE) |
 |
Eve Doran | The role of human pentraxins in the Leishmania vector lifecycle | Matthew Rogers John Raynes Matthew Yeo |
LSHTM | MRC LID 1 Cohort 4 (2019-20) |
RD only (3.5 years FTE) |
 |
Nicholas Eckersley | Detection of infectious diseases in febrile patients in field studies in Gabon using molecular assays including next generation diagnostics | Henry Staines David Allen |
SGUL | MRC LID 1 Cohort 4 (2019-20) |
RD only (3.5 years FTE) iCASE |
 |
Georgia Gore-Langton | Investigating the pathways to adverse pregnancy outcomes among women infected with malaria infection and/or sexually transmitted/reproductive tract infections during pregnancy in sub-Saharan Africa | Matt Chico Matt Cairns John Bradley Asma Khalil |
LSHTM | MRC LID 1 Cohort 4 (2019-20) |
RD only (3.5 years FTE) |
 |
Robert Greener | Simulating the impact of transport interventions on physical activity and cardiovascular disease using agent-based models | Steve Cummins Daniel Lewis |
LSHTM | MRC LID 1 Cohort 4 (2019-20) |
Masters & RD (1+3 years FTE) |
 |
Sally Hayward | The relationship between psychosocial stress, immune function, and tuberculosis risk among migrants | Jon Friedland Sally Hargreaves Delia Boccia |
SGUL | MRC LID 1 Cohort 4 (2019-20) |
RD only (3.5 years FTE) |
 |
Penny Sparkes | Exploring how energy metabolism differs in male and female Plasmodium falciparum gametocytes | Michael Delves David Baker |
LSHTM | MRC LID 1 Cohort 4 (2019-20) |
RD only (3.5 years FTE) |
 |
Ian Storey | MRI Radiomics of adult brain tumours | Franklyn Howe Xujiong Ye Timothy Jones |
SGUL | MRC LID 1 Cohort 4 (2019-20) |
RD only (3.5 years FTE) |
 |
Tansy Vallintine | Shining a light on the dense granules of malaria parasites | Christiaan van Ooij Henry Staines |
LSHTM | MRC LID 1 Cohort 4 (2019-20) |
RD only (3.5 years FTE) |
 |
Emily Woodcock | A new approach to understanding cancer metabolism | Elena Sviderskaya Yuri Korchev Feran Valderrama |
SGUL | MRC LID 1 Cohort 4 (2019-20) |
RD only (3.5 years FTE) iCASE |
 |
Claire Broad | Detecting sexual bridges: rapid genome-mapping of sexually transmitted infections among female sex worker and non-sex worker populations in Ecuador | Tariq Sadiq Philip Cooper |
SGUL | MRC LID 1 Cohort 3 (2018-19) |
RD only (3.5 years FTE) |
 |
Rhodri Edwards | Novel control strategies for Lutzomyia longiplpis sand flies through CRISPR-Cas9 genetic modification of olfaction and Wolbachia transinfection | Matthew Yeo Thomas Walker Matthew Rogers |
LSHTM | MRC LID 1 Cohort 3 (2018-19) |
RD only (3.5 years FTE) |
 |
Oliver Hines | Development of high-dimensional data-adaptive causal inference methods to unravel the role of genetics in determining heart rhythm | Karla Diaz-Ordiz Yalda Jamshidi James Carpenter |
LSHTM | MRC LID 1 Cohort 3 (2018-19) |
RD only (3.5 years FTE) |
 |
Harriet Jones | Developing a data system to inform real-time public health action among female sex workers in Zimbabwe | James Hargreaves Bernadette Hensen |
LSHTM | MRC LID 1 Cohort 3 (2018-19) |
RD only (3.5 years FTE) |
 |
Charlotte Kerr | A “One Health” approach to investigating the epidemiology and control of human Brucellosis and Q-fever in peri-urban areas of two sub-Saharan African countries | Patrick Nguipdop-Djomo Punam Mangtani |
LSHTM | MRC LID 1 Cohort 3 (2018-19) |
RD only (3.5 years FTE) |
 |
Quentin Leclerc | What drives antibiotic resistance diversity? Modelling for MRSA control | Gwen Knight Jodi Lindsay |
LSHTM | MRC LID 1 Cohort 3 (2018-19) |
RD only (3.5 years FTE) |
 |
Eleanor Rees | Modelling leptospirosis at the animal-human interface in island populations | Adam Kucharski Rachel Lowe John Edmunds |
LSHTM | MRC LID 1 Cohort 3 (2018-19) |
RD only (3.5 years FTE) |
 |
Rebecca Roscoe | Targeting nutrient uptake and salvage pathways in Trypanosoma cruzi | Martin Taylor John Kelly |
LSHTM | MRC LID 1 Cohort 3 (2018-19) |
RD only (3.5 years FTE) |
 |
Katharine Sherratt | Mapping changes in the burden of dengue in the Philippines | Oliver Brady Laith Yakob |
LSHTM | MRC LID 1 Cohort 3 (2018-19) |
RD only (3.5 years FTE) |
 |
Alicia Showering | Microbiomics and genetics of human attractiveness to malaria mosquitoes | James Logan Rachel Allen Robert Butcher Chrissy Roberts |
LSHTM | MRC LID 1 Cohort 3 (2018-19) |
Masters & RD (1+3 years FTE) |
 |
James Ashall | Immunology, molecular biology and control of flaviviruses (Dengue and Zika) | Martin Hibberd Julius Hafalla |
LSHTM | MRC LID NPIF (2017-18) |
RD only (3.5 years FTE) |
 |
Matthew Biggart | Proteomic profiling of the lung epithelium to identify targets and treatments for the prevention of diabetes associated lung infection | Emma Baker Deborah Baines |
SGUL | MRC LID NPIF (2017-18) |
RD only (3.5 years FTE) |
 |
Grace Macklin | Development of targeted vaccination strategies during disease elimination | Kathleen O’Reilly Sebastian Funk |
LSHTM | MRC LID NPIF (2017-18) |
RD only (3.5 years FTE) |
 |
Naomi Waterlow (Walker) | Modelling interactions between respiratory viruses and immune responses | Rosalind Eggo Stefan Flasche |
LSHTM | MRC LID NPIF (2017-18) |
RD only (3.5 years FTE) |
 |
Egle Butkeviciute | Does the BCG vaccine protect infants from severe forms of childhood tuberculosis by trained innate and humoral mechanisms? | Hazel Dockrell Christine Jones Steve Smith |
LSHTM | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Faye Cleary | Applying Bayesian models and machine learning algorithms in large datasets of electronic healthcare records to investigate the burden and consequences of progressive kidney disease | Dorothea Nitsch David Prieto-Merino |
LSHTM | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Paula Gomez Gonzalez | Whole-genome sequence analysis of Mycobacterium tuberculosis to identify the genetic determinants and mechanisms of anti-tuberculosis drug resistance | Taane Clark Phillip Butcher |
LSHTM | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Mark Harrison | The interaction between Clostridium difficile, the intestinal microbiome and disease outcome | Lisa Dawson Brendan Wren |
LSHTM | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Amy Ibrahim | Using whole genome sequence data to develop molecular barcodes to profile Plasmodium malaria parasites | Susana Campino Taane Clark |
LSHTM | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Emma Powell | Can observational data be used to determine drug effectiveness? | Kevin Wing Ian Douglas |
LSHTM | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Miguel Pugliese Garcia | Exploring the influence of context on complex, health system strengthening interventions: a mixed methods study of Performance-based financing | Melisa Martinez-Alvarez Tanya Marchant Josephine Borghi |
LSHTM | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Alexis Robert | Modelling social clustering of susceptibles and its impact on measles elimination | Sebastian Funk Stephane Hue Adam Kucharski |
LSHTM | MRC Vaccines DTC/ MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Darren Scott | Bayesian methods for simultaneous clustering and variable selection | Alex Lewin Taane Clark |
LSHTM | MRC LID 1 Cohort 2 (2017-18) |
RD only (3 years FTE) |
 |
Nathan Simpson | Novel drugs against superbugs – preclinical optimizations | Kai Hilpert Deborah Baines |
SGUL | MRC LID 1 Cohort 2 (2017-18) |
Masters & RD (1+3 years FTE) |
 |
Abigail Sunderland | Risk of sexual transmission of Zika virus infection: a study among sex workers and their clients in an endemic area of coastal Ecuador | Phil Cooper Tariq Sadiq |
SGUL | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Stanislavs Vasiljevs | Investigation of diabetes mellitus induced changes to the respiratory microbiota and its use as a predictor of susceptibility to infection | Deborah Baines Adam Witney |
SGUL | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Chathika Weerasuriya | Mathematical modelling to accelerate development of tuberculosis vaccines | Richard White Gabriela Gomez Rebecca Harris |
LSHTM | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Karolina Witt | Enhancing TB vaccine immunity by natural selection of protective CTL epitopes | Tim Bull | SGUL | MRC LID 1 Cohort 2 (2017-18) |
RD only (3.5 years FTE) |
 |
Natasha Clarke | Digital discourse as clinical data | Peter Garrard Thomas Barrick |
SGUL | MRC LID 1 Cohort 1 (2016-17) |
RD only (3.5 years FTE) |
 |
Alasdair Henderson | Spatial transmission of influenza and dengue fever in the Western Pacific | Adam Kucharski John Edmunds |
LSHTM | MRC LID 1 Cohort 1 (2016-17) |
RD only (3.5 years FTE) |
 |
Poppy Mallinson | Investigating effect of rural-urban migration on cardiovascular health outcomes in Brazil using national routine data | Sanjay Kinra Laura Rodrigues |
LSHTM | MRC LID 1 Cohort 1 (2016-17) |
RD only (3.5 years FTE) |
 |
James Orsborne | Mosquito biting behaviour and arboviral transmission: interactions between intrinsic host preferences and local environmental conditions | Laith Yacob Tom Walker |
LSHTM | MRC LID 1 Cohort 1 (2016-17) |
RD only (3.5 years FTE) |
 |
Hannah Painter | Accelerating the development of effective mucosal vaccines for protection against Mycobacterium tuberculosis | Helen Fletcher Rajko Reljic |
LSHTM | MRC LID 1 Cohort 1 (2016-17) |
RD only (3.5 years FTE) |
 |
Charlotte Rutter | Multi-level modelling of international variations and time trends in asthma and allergic diseases in children and adults | Neil Pearce David Strachan Richard Silverwood |
LSHTM | MRC LID 1 Cohort 1 (2016-17) |
RD only (3.5 years FTE) |
 |
John Tazare | Exploring biases in propensity score analyses of electronic health record data | Elizabeth Williamson Ian Douglas |
LSHTM | MRC LID 1 Cohort 1 (2016-17) |
RD only (3.5 years FTE) |
 |
Alexander Ward | Investigating parasite persistence and latency in chronic Chagas disease | John Kelly Martin Taylor |
LSHTM | MRC LID 1 Cohort 1 (2016-17) |
RD only (3.5 years FTE) |
 |
Karen Zamboni | Process analysis of the Safe Care, Saving Lives initiative to improve neonatal health in Telangana and Andhra Pradesh, India | Claudia Hanson Joanna Schellenberg |
LSHTM | MRC LID 1 Cohort 1 (2016-17) |
RD only (3.5 years FTE) |
 |
Catherine Hall | Vaccine development for Clostridium difficile | Brendan Wren | LSHTM | MRC Vaccines DTC Cohort 4 (2015-16) |
RD only 3.5 years FTE) |
 |
Gurdip Mann | Using In Vivo Imaging to help study the immunology of T. cruzi infection and to test the efficacy of viral vectored vaccines against this parasite | John Kelly | LSHTM | MRC Vaccines DTC Cohort 4 (2015-16) |
RD only 3.5 years FTE) |
 |
Helen Wagstaffe | The role of Natural Killer cells in killing virus infected cells after vaccination | Eleanor Riley Martin Goodier |
LSHTM | MRC Vaccines DTC Cohort 4 (2015-16) |
RD only 3.5 years FTE) |
 |
Mateusz Hasso Agopsowicz | Investigation of variations in immune responses of UK and Ugandan infants following BCG vaccination | Steven Smith | LSHTM | MRC Vaccines DTC Cohort 3 (2014-15) |
RD only 3.5 years FTE) |
 |
Lisa Stockdale | Investigation of Immune Correlates and impact of immune activation on Tuberculosis Disease risk | Helen Fletcher | LSHTM | MRC Vaccines DTC Cohort 3 (2014-15) |
RD only 3.5 years FTE) |
 |
Lindsey Wu | Design of a Phase III cluster randomised trial to assess safety and efficacy of a malaria transmission blocking vaccine | Chris Drakely | LSHTM | MRC Vaccines DTC Cohort 3 (2014-15) |
RD only 3.5 years FTE) |
| Harvey Aspeling-Jones | Dissecting antibody-mediated inhibition of Plasmodium falciparum merozoites protocol | David Conway | LSHTM | MRC Vaccines DTC Cohort 2 (2013-14) |
RD only 3.5 years FTE) |
|
| Katherine Gallagher | Evaluating Human Papillomavirus (HPV) vaccine introduction in Tanzania and other low-resource settings | Deborah Watson-Jones | LSHTM | MRC Vaccines DTC Cohort 2 (2013-14) |
RD only 3.5 years FTE) |
|
| Rebecca Harris | Estimating the potential impact of new TB vaccines and supporting epidemiological needs for TB vaccine research | Richard White | LSHTM | MRC Vaccines DTC Cohort 2 (2013-14) |
RD only 3.5 years FTE) |
|
| Samuel Thorburn | Understanding T cell mediated immune mechanisms against malaria liver stages for vaccine discovery | Julius Hafalla | LSHTM | MRC Vaccines DTC Cohort 2 (2013-14) |
RD only 3.5 years FTE) |
|
| Carolyn Nielson | Tne impact of cytomegalovirus infection on natural killer cell responses to vaccines | Eleanor Riley | LSHTM | MRC Vaccines DTC Cohort 1 (2012-13) |
RD only 3.5 years FTE) |
|
| Conall Watson | The transmission of Salmonella Typhi and the role of vaccination in typhoid fever control | John Edmunds | LSHTM | MRC Vaccines DTC Cohort 1 (2012-13) |
RD only 3.5 years FTE) |